Currently, Nicholas Ede holds the position of Chief Technology Officer for Imugene Ltd.

He is also on the board of Eden Peptide Pty Ltd.

In the past Dr. Ede occupied the position of Chief Executive Officer of Adistem Pty Ltd., Chief Technology Officer for Rhinomed Ltd., Chief Executive Officer of Mimotopes Pty Ltd., Chief Operating Officer of Equatorial Coal Ltd. and Vice President-Chemistry at Novartis Australia Pty Ltd.

He received a doctorate from Monash University.